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AbstrAct
Objective: To verify if the type of donor is a risk factor for infection in kidney transplant 
recipients. Methods: Systematic Review of Literature with Meta-analysis with searches 
conducted in the databases MEDLINE, LILACS, Embase, Cochrane, Web of Science, 
SciELO and CINAHL. Results: We selected 198 studies and included four observational 
studies describing infections among patients distinguishing the type of donor. Through 
meta-analysis, it was shown that in patients undergoing deceased donor transplant, the 
outcome infection was 2.65 higher, than those who received an organ from a living donor. 
Conclusion: The study showed that deceased kidney donor recipients are at an increased 
risk for developing infections and so the need for establishing and enforcing protocols 
from proper management of ischemic time to the prevention and control of infection in 
this population emerges.
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INTRODUCTION
Kidney transplantation was introduced as large scale 
replacement therapy in the 1960s, achieving significant 
growth in the 1980s(1).
The introduction of new immunosuppressive agents 
provided significant reduction in the incidence of acute re-
jection (AR)(1).
As criteria for kidney transplantation, we considered: 
medical, surgical and psychosocial assessment of the patient. 
Exams and assessment of compatibility with the potential 
donor (HLA-Human Leukocyte Antigens)(1-3).
Absolute and relative contraindications for patient 
transplantation are: active infection, low survival progno-
sis, severe psychiatric problems, uncontrolled psychosis, 
addiction, heart disease, active hepatitis and possible non-
adherence to treatment. It is not included among the con-
traindications: advanced age, and previous transplants(1-2).
In the year 2014, according to the Brazilian Society 
of Nephrology, the number of people with kidney disease, 
in Brazil, was on the order of 54.000, it was estimated 
that 48,198 required hemodialysis and only 6.2% of pa-
tients with chronic renal failure were submitted to kidney 
transplantation.
In 2010, in the period from January to June 1,486 kid-
ney transplants were carried out, a 21% increase over the 
same period from the previous year. In 2013 5,433 kidney 
transplants were performed in Brazil. This increase can be 
explained by a possible increase in collection of organs due 
to a greater awareness of Brazilian society and the growth 
of access to treatment in the period(3).
The huge challenge in kidney transplantation is the 
management of infectious complications which signifi-
cantly increase morbidity and mortality in this population(4). 
Several risk factors related to infectious complications are 
present after kidney transplantation, highlighting the need 
for ongoing use of immunosuppression, socioeconomic 
conditions, HLA compatibility and donor type(5-6). The in-
cidence of post-renal transplant infections complications 
found in the literature ranges from 49% to 80%(7-10).
Motivated by the problem of infections in kidney trans-
plant patients and the significant increase in transplants, es-
pecially kidney recipients of deceased donors, we performed 
a Systematic Review of Literature with Meta-analysis in 
order to determine whether the type of donor is a risk factor 
associated with developing infections.
METHOD
Ethical aspects: The study was approved by the Re-
search Ethics Committee of the Universidade Federal de 
Sao Paulo, Unifesp, protocol 56526.
STUDy pROTOCOl
This Systematic Review with Meta-analysis followed 
the methodology proposed by the Cochrane Collabora-
tion(11). The search for studies was carried out regardless of 
the language or form of publication and with the following 
research designs: randomized controlled trials, quasi-exper-
imental studies, prospective and retrospective observational 
cohort studies and cross-sectional studies.
Inclusion criteria: We included studies that evaluated the 
outcome presence of infection with the comparison type 
of donor.
SeaRCh STRaTegy fOR IDeNTIfICaTION Of STUDIeS
Studies were identified through electronic search in 
PubMed ( January1966 to January 2014), LILACS ( Janu-
ary 1982 to January 2014), Embase January 1985 to January 
2014), SciELO ( June 1998 to January 2014), The Cochrane 
Library (including the Cochrane Controlled Trials Register, 
contained in the Cochrane Library 2014), Web of Science 
(1945 to January 2014) and CINAHL ( January 1981 to 
January 2014). We also searched the database www.con-
troledtrials.com and conference abstracts, references of re-
view articles and systematic review, published and references 
of randomized clinical trials identified until January 2014.
The search strategy was developed in MEDLINE, 
through PubMed, as shown in Figure 1, adapted to all other 
databases mentioned.
(“kidney”[MeSH Terms] OR “kidney”[All 
Fields]) AND (“tissue donors”[MeSH Terms] OR 
(“tissue”[All Fields] AND “donors”[All Fields]) OR 
“tissue donors”[All Fields] OR “donor”[All Fields]) 
AND (“infection”[MeSH Terms] OR “infection”[All 
Fields] OR “communicable diseases”[MeSH Terms] 
OR (“communicable”[All Fields] AND “diseases”[All 
Fields]) OR “communicable diseases”[All Fields]) AND 
type[All Fields] AND (“tissue donors”[MeSH Terms] 
OR (“tissue”[All Fields] AND “donors”[All Fields]) OR 
“tissue donors”[All Fields] OR “donor”[All Fields])
Figure 1 – Specific terms used for the search in electronic data-
bases.
MeThODS Of RevIew
Complete copies of all relevant studies were read in 
order to establish whether the studies met the inclusion 
criteria, assessment of methodological quality by two inde-
pendent reviewers, A and B. In case of doubt or disagree-
ment, another reviewer, C, was requested to settle.
aSSeSSMeNT Of MeThODOlOgICal qUalITy aND 
STaTISTICal aNalySIS
The assessment of methodological quality, defined as the 
confidence that the design and the study report are free 
of bias(11), we conducted it using the recommendations of 
Strengthening the Reporting of Observational Studies in 
Epidemiology Statement (STROBE)(12). Based on these 
recommendations the assessment of studies was divided 
into three categories: A - in the case of studies fulfil a value 
equal to or greater than 80% of the established criteria; B 
- reaching 80% and 50% of criteria; and C - reaching less 
than 50% of the established criteria.
The software Review Manager 5.1, available from 
The Cochrane Collaboration was used in the statistical 
analysis(13-14).
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For dichotomous variables, we used odds ratio (OR) 
with 95% confidence interval, calculated by the random 
and fixed effect models. We also calculate the square I- (I2) 
of Mantael-Haenzel(14) to search for heterogeneity. I2 values 
greater than or equal to 50% are considered heterogeneous. 
The heterogeneity test is only calculated when the meta-
analysis contains two or more studies.
ReSUlTS
According to the descriptors shown in Figure 1, 198 
studies were found in the databases PubMed, LILACS, 
Embase, SciELO, The Cochrane Library, Web of Science 
and CINAHL.
The screening of titles and abstracts of studies followed 
the Cochrane methodology available in the Handbook(11).
A total of 14 studies, all available in English were in-
cluded. Of these, five studies were included for full-text 
reading. After contacting an author, one study was excluded 
and only four studies met the inclusion criteria and present-
ed the outcome infection among kidney transplants from 
living versus deceased donors.
The studies included in this review are observational, 
being two retrospective cohort and two prospective.
Chart 1 shows the description of the studies and the 
methodological quality.
The Chart 1 presents a description of the included 
studies. It was observed that most donors were deceased, 
reflecting the national and international policies for organ 
donation stimulus. The Brazilian study which included the 
largest number of participants, as Brazil is the 2nd country 
in transplant numbers and this study was conducted at the 
national reference center for Kidney Transplantation.
Chart 1 – Description of included studies and assessment of methodological quality.
Publication and year country type of study
No transplant/
donor living versus 
deceased
(prevalence)
episodes of 
infection/ living 
versus deceased 
donors
Microorganisms site of infection strobe
Kee T et al.,
2004(15) Singapore
Prospective 
cohort
1982-2002
658/67 (9.8) 57/10 E. coli; K. sspand S. aureus
UTI and
BSI B
Charfeddine K et al., 
2005(16) Tunisia
Propective 
cohort
1994-2003
18/30 (0.6) 9/23 Not described Not described B
Alangaden GJ et al., 
2006(9) EUA
Retrospective 
cohort
2001-2004
94/33 (2.8) 63/2
S aureus, M. 
catarrhalis and E.
agglomerans
UTI, PNM BSI C
Sousa SR et al., 
2010(7) Brazil
Retrospective 
cohort
2006-2010
487/334 (1.4) 338/139
E. coli, E. sp,
k. pneumoniae,
P. aeruginosa
UTI, SSI
and BSI C
*UTI: urinary tract infection, PNM: Pneumonia, BSI: Bloodstream infection, SI: Surgical Site Infection
181 were excluded after screening the 
title and abstracts of the studies
Five studies were selected and 
included in the study
198 studies identified in the 
searches
14 studies were included
Four studies were included in 
the meta-analysis
Nine full-text studies were excluded 
because the type of donor who 
developed infection was not described
One study was excluded after 
contacting the author
Figure 2 – Flowchart for the identification and selection of studies.
 
Study or Subgroup
Alangaden GJ et al, 2006
Charfeddine K et al, 2005
Kee T et al. 2004
Sousa SR et al, 2010
Total (95% CI)
Total events
Heterogeneity: Chi² = 42.02, df = 3 (P < 0.00001); I² = 93%
Test for overall effect: Z = 7.51 (P < 0.00001)
Events
63
9
57
338
467
Total
94
18
658
487
1257
Events
2
23
10
139
174
Total
33
30
67
334
464
Weight
1.3%
11.3%
21.6%
65.8%
100.0%
M-H, Fixed, 95% CI
31.50 [7.08, 140.21]
0.30 [0.09, 1.07]
0.54 [0.26, 1.12]
3.18 [2.38, 4.26]
2.65 [2.05, 3.41]
deceased donor live donor Odds Ratio Odds Ratio
M-H, Fixed, 95% CI
0.001 0.1 1 10 1000
Favours [experimental] Favours [control]
Legend: CI: Confidence Interval
M-H: Mantel-Haenszel
Figure 3 – Infectious events: deceased donor versus living donor.
Among the most common infections described in the 
studies were Urinary Tract Infections and the microorgan-
ism related was E. coli. Such data are in agreement with 
the literature.
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Figure 3 demonstrates a greater risk for the group of 
patients transplanted from deceased donors in relation to 
the group of living donors for the outcome infection with 
an odds ratio of 2.65 (95% confidence interval from 2.05 to 
3.41 p <0.00001). The heterogeneity among the included 
studies was I2=93%, p <0.00001, which can be explained by 
the low number of studies that met the inclusion criteria.
DISCUSSION
In order to conduct a systematic review is imperative 
to follow the appropriate methodology with all the neces-
sary scientific rigor, avoiding biases and inaccuracies, which 
makes it different from narrative and traditional literature 
review(14-15).
The best way to control biases in a systematic review is 
to include randomized controlled trials as recommended 
by Cochrane Collaboration, which was not possible in this 
review, being composed of observational studies, which is 
appropriate design to analyze the expected outcomes. An 
alternative to minimize biases that the study is subject, was 
to use the STROBE instrument for assessing the method-
ological quality of observational studies. This instrument 
provides recommendations for critical and transparent anal-
ysis of the data of this type of study to assess what results 
can be included in a systematic review(12,17-18,20).
Through meta-analysis is possible to obtain a higher sta-
tistical power, because data from more than one study are 
combined, increase the sample size, and thus the statistical 
power, thus reducing the possibility of incorrect acceptance 
or rejection of the null hypothesis(19).
The number of transplants in Brazil increased from 
920 in 1988 to 5,639 in 2014, highlighting Brazil as the 
second major kidney transplant center in the world(3). The 
relationship between the number of transplants with living 
and deceased organ donors remains close to 50% between 
1994 and 2007. The proportion of transplants with deceased 
organ donors has grown substantially, and in 2014, among 
the 5,639 kidneys transplanted around country, 4,251 were 
performed with organs from deceased donors(3).
The first objective of the study was to analyze if the 
type of donor is infection risk factor for the recipient, and 
was evidenced figure 3 that the deceased donor was a risk 
factor 2.65 for the outcome infection in kidney transplant 
patients with an odds ratio 2.65, 95% CI (2.05 to 3.41, 
p <0.00001).
Among the various conditions studied that show sig-
nificant association with the risk of developing infectious 
episodes after kidney transplantation, we highlight those 
related to cold ischemia time on the graft and the immune 
factors(7,21).
A study conducted in a referral center for kidney trans-
plantation in Brazil showed that the increase of 30 minutes 
in the cold ischemia time on the graft from deceased do-
nor had a significant and independent association with the 
risk of developing infectious episodes (OR 3.29, 95% CI 
2.37–4.58)(7).
It is known that prolonged tissue ischemia facilitates 
and amplifies the exposure classes of MHC class I and II 
antigens of the transplanted organ to the immune system 
of the recipient, favoring immune recognition and raising 
the chances of triggering the rejection process(20). Another 
important variable for graft patient survival is delayed graft 
function (DGF), which is directly related to negative out-
comes of transplantation, including graft loss and risk of 
infection(21).
Although the incidence of infectious episodes are 
highly variable among the different studies, usually the 
incidence of infection is higher in the first month follow-
up after transplantation and directly related to the dose of 
immunosuppression used. In the first months after kid-
ney transplantation predominant nosocomial infections, 
especially those located in the urinary tract and surgical 
wound (7,9-10).
The microbiology of infections in post-kidney trans-
plantation tends to follow patterns directly related to the 
type and intensity of immunosuppression therapy and 
prophylaxis of these components has been significantly 
effective in reducing the incidence of opportunistic early 
infections(9).
In kidney transplantation patients, infection is one of 
the main causes of hospital admissions and represents 51% 
of readmissions that occur within six months after trans-
plantation, preceded only by surgical complications(22).
A study conducted with 280 transplant patients at the 
Universidade Federal de Sao Paulo showed that coloniza-
tion by Vancomycin-resistant Enterococcus in this popula-
tion was 14.5%(23). And recently demonstrated by molecular 
typing of isolated bacteria from this population that cross-
transmission of multi-resistant bacteria happens among 
these patients(24).
Added to this, the number of patients on the waiting 
list for a kidney transplant is large and annually presents an 
increasing trend, this is due to progressive improvement in 
the quality and life expectancy afforded by dialysis interven-
tions(25-26). Facing this scenario, there is a need for further 
studies aiming to establish protocols for the management 
of deceased donor transplant, aiming at the reduction of 
related infection.
CONClUSION
This systematic review and meta-analysis has revealed 
that deceased kidney donor recipients have 20% higher risk 
for developing infections.
ImplIcatIons for practIce
This study points to the need for new studies that show 
ways to minimize the reduction in infection with deceased 
donor transplant patients. In short term, the implementa-
tion of protocols to reduce cold ischemia time on the organ 
and proper preservation would be possible; review of pro-
tocols and screening of deceased donors to detect serologi-
cal conditions and body integrity; strict adherence with the 
existing protocols for prevention and control of multidrug-
resistant bacteria in order to reduce morbidity and mortality 
related to infection in this patient population.
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resUMo
Objetivo: Verificar se o tipo de doador é fator de risco para infecção nos pacientes transplantados renais. Método: Revisão Sistemática 
da Literatura com Metanálise realizada nas bases de dados MEDLINE, LILACS, Embase, Cochrane, Web of Science, SciELO 
e CINAHL. Resultados: Foram selecionados 198 artigos e incluídos quatro estudos observacionais que descreveram as infecções 
apresentadas entre os pacientes distinguindo o tipo de doador. Através da metanálise, foi evidenciado que em pacientes submetidos a 
transplante de doador falecido, o desfecho infecção foi 2,65 maior, em relação aos que recebem o órgão de doador vivo. Conclusão: O 
estudo permitiu verificar que receptores de rim de doador falecido apresentam maior risco para o desenvolvimento de infecções e que 
emerge a necessidade de estabelecimento e cumprimento de protocolos desde o manejo adequado do tempo de isquemia à prevenção e 
controle de infecção nesta população.
descritores
Transplante de Rim; Doadores de Tecidos; Doadores Vivos; Infecção; Revisão.
resUMeN
Objetivo: Verificar si el tipo de donante es factor de riesgo para infección en los pacientes trasplantados renales. Método: Revisión 
Sistemática de la Literatura con Metanálisis llevado a cabo en las bases de datos MEDLINE, LILACS, Embase, Cochrane, Web 
of Science, SciELO y CINAHL. Resultados: Se seleccionaron 198 artículos y se incluyeron cuatro estudios observacionales que 
describieron las infecciones presentadas entre los pacientes, distinguiéndose el tipo de donante. Mediante el metanálisis, se evidenció 
que en pacientes sometidos a trasplante de donante fallecido, el resultado infección fue 2,65 mayor, con relación a quienes reciben el 
órgano de donante vivo. Conclusión: El estudio permitió verificar que receptores de riñón de donante fallecido presentan mayor riesgo 
para el desarrollo de infecciones y que emerge la necesidad de establecimiento y cumplimiento de protocolos desde el manejo adecuado 
del tiempo de isquemia hasta la prevención y el control de infección en esa población.
descriPtores
Trasplante de Riñón; Donantes de Tejidos; Donadores Vivos; Infección; Revisión.
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